DrugPatentWatch Database Preview
NORTHERA Drug Profile
» See Plans and Pricing
When do Northera patents expire, and what generic alternatives are available?
Northera is a drug marketed by Lundbeck Na Ltd and is included in one NDA.
The generic ingredient in NORTHERA is droxidopa. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the droxidopa profile page.
Summary for NORTHERA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 71 |
| Clinical Trials: | 16 |
| Patent Applications: | 107 |
| Drug Prices: | Drug price information for NORTHERA |
| DailyMed Link: | NORTHERA at DailyMed |
Recent Clinical Trials for NORTHERA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| William Ondo, MD | Phase 4 |
| Lundbeck LLC | Phase 4 |
| Arizona State University | Phase 2 |
Pharmacology for NORTHERA
| Physiological Effect | Increased Blood Pressure |
US Patents and Regulatory Information for NORTHERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lundbeck Na Ltd | NORTHERA | droxidopa | CAPSULE;ORAL | 203202-001 | Feb 18, 2014 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Lundbeck Na Ltd | NORTHERA | droxidopa | CAPSULE;ORAL | 203202-002 | Feb 18, 2014 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Lundbeck Na Ltd | NORTHERA | droxidopa | CAPSULE;ORAL | 203202-003 | Feb 18, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
